93 LOW DOSE INTRAVENOUS IMMUNOGLOBULIN IN THE TREATMENT OF LONGSTANDING CRPS
β Scribed by A. Goebel; A. Ghiai; K. Maurer; D. Colbeck; K. Ayazi; A. Woo; C. McCabe; B. Brandner; G. Ambler; A. Baranowski
- Book ID
- 108487438
- Publisher
- Elsevier Science
- Year
- 2009
- Tongue
- English
- Weight
- 44 KB
- Volume
- 13
- Category
- Article
- ISSN
- 1090-3801
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
In patients with Haemophilia A, the development of inhibitor is a life-threatening complication of treatment. These patients are at high risk for dangerous bleeding as a result of this acquired resistance to human Factor VIII concentrate. Although treatment of bleeding complications has been improve
Infection with the human immunodeficiency virus (HIV) frequently is complicated with thrombocytopenia (HIV-Thr) during all stages of the infection. The treatments for autoimmune thrombocytopenic purpura (ITP) are used in HIV-Thr; however, their effects upon the immune status of patients with acquire
ITP in pregnancy may lead to fetal thrombocytopenia caused by the transplacental passage of maternal antiplatelet antibody. The most hazardous complication in the infant is intracranial hemorrhage. In addition ITP in pregnancy is reported to be associated with an increased abortion rate and an eleva
In children infected with human immunodeficiency virus (HIV) placebo-controlled trials with intravenous immunoglobulins have resulted in a significant reduction in morbidity; however, the results of small trials in adolescents and adults have been inconsistent. In this study 17 HIV-infected hemophil